USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

Abstract Ubiquitin-specific protease 3 (USP3) plays an important role in the progression of various tumors. However, the role of USP3 in osteosarcoma (OS) remains poorly understood. The aim of this study was to explore the biological function of USP3 in OS and the underlying molecular mechanism. We...

Full description

Bibliographic Details
Main Authors: Anan Li, Shijiang Wang, Jiangbo Nie, Shining Xiao, Xinsheng Xie, Yu Zhang, Weilai Tong, Geliang Yao, Ning Liu, Fan Dan, Zhiguo Shu, Jiaming Liu, Zhili Liu, Feng Yang
Format: Article
Language:English
Published: Nature Publishing Group 2024-03-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-06624-7
_version_ 1797233228380110848
author Anan Li
Shijiang Wang
Jiangbo Nie
Shining Xiao
Xinsheng Xie
Yu Zhang
Weilai Tong
Geliang Yao
Ning Liu
Fan Dan
Zhiguo Shu
Jiaming Liu
Zhili Liu
Feng Yang
author_facet Anan Li
Shijiang Wang
Jiangbo Nie
Shining Xiao
Xinsheng Xie
Yu Zhang
Weilai Tong
Geliang Yao
Ning Liu
Fan Dan
Zhiguo Shu
Jiaming Liu
Zhili Liu
Feng Yang
author_sort Anan Li
collection DOAJ
description Abstract Ubiquitin-specific protease 3 (USP3) plays an important role in the progression of various tumors. However, the role of USP3 in osteosarcoma (OS) remains poorly understood. The aim of this study was to explore the biological function of USP3 in OS and the underlying molecular mechanism. We found that OS had higher USP3 expression compared with that of normal bone tissue, and high expression of USP3 was associated with poor prognosis in patients with OS. Overexpression of USP3 significantly increased OS cell proliferation, migration, and invasion. Mechanistically, USP3 led to the activation of the PI3K/AKT signaling pathway in OS by binding to EPHA2 and then reducing its protein degradation. Notably, the truncation mutant USP3-F2 (159–520) interacted with EPHA2, and amino acid 203 was found to play an important role in this process. And knockdown of EPHA2 expression reversed the pro-tumour effects of USP3-upregulating. Thus, our study indicates the USP3/EPHA2 axis may be a novel potential target for OS treatment.
first_indexed 2024-04-24T16:12:50Z
format Article
id doaj.art-0c0efc77bab74c9bad86f8459b463001
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-24T16:12:50Z
publishDate 2024-03-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-0c0efc77bab74c9bad86f8459b4630012024-03-31T11:37:02ZengNature Publishing GroupCell Death and Disease2041-48892024-03-0115311210.1038/s41419-024-06624-7USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathwayAnan Li0Shijiang Wang1Jiangbo Nie2Shining Xiao3Xinsheng Xie4Yu Zhang5Weilai Tong6Geliang Yao7Ning Liu8Fan Dan9Zhiguo Shu10Jiaming Liu11Zhili Liu12Feng Yang13Orthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityMedical Innovation Center, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityOrthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityAbstract Ubiquitin-specific protease 3 (USP3) plays an important role in the progression of various tumors. However, the role of USP3 in osteosarcoma (OS) remains poorly understood. The aim of this study was to explore the biological function of USP3 in OS and the underlying molecular mechanism. We found that OS had higher USP3 expression compared with that of normal bone tissue, and high expression of USP3 was associated with poor prognosis in patients with OS. Overexpression of USP3 significantly increased OS cell proliferation, migration, and invasion. Mechanistically, USP3 led to the activation of the PI3K/AKT signaling pathway in OS by binding to EPHA2 and then reducing its protein degradation. Notably, the truncation mutant USP3-F2 (159–520) interacted with EPHA2, and amino acid 203 was found to play an important role in this process. And knockdown of EPHA2 expression reversed the pro-tumour effects of USP3-upregulating. Thus, our study indicates the USP3/EPHA2 axis may be a novel potential target for OS treatment.https://doi.org/10.1038/s41419-024-06624-7
spellingShingle Anan Li
Shijiang Wang
Jiangbo Nie
Shining Xiao
Xinsheng Xie
Yu Zhang
Weilai Tong
Geliang Yao
Ning Liu
Fan Dan
Zhiguo Shu
Jiaming Liu
Zhili Liu
Feng Yang
USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
Cell Death and Disease
title USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
title_full USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
title_fullStr USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
title_full_unstemmed USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
title_short USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
title_sort usp3 promotes osteosarcoma progression via deubiquitinating epha2 and activating the pi3k akt signaling pathway
url https://doi.org/10.1038/s41419-024-06624-7
work_keys_str_mv AT ananli usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT shijiangwang usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT jiangbonie usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT shiningxiao usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT xinshengxie usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT yuzhang usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT weilaitong usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT geliangyao usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT ningliu usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT fandan usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT zhiguoshu usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT jiamingliu usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT zhililiu usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway
AT fengyang usp3promotesosteosarcomaprogressionviadeubiquitinatingepha2andactivatingthepi3kaktsignalingpathway